HIGHLIGHTS: Mala Gaonkar - Founder of SurgoCap Partners

What It Covers

Mala Gaonkar, founder of SurgoCap Partners, explains her concentrated investment strategy focused on four verticals: enterprise data, financial services, healthcare, and industrial technologies. She grew the fund from $1.8 billion to $6 billion by identifying businesses with long-duration competitive moats.

Key Questions Answered

• •Duration-focused moats: SurgoCap identifies great businesses by analyzing their technology stack maps, particularly in non-tech sectors like aerospace and medtech. The firm concentrates investments in four verticals where technology disruption creates durable competitive advantages, allowing companies to deploy capital at high incremental returns over three to five year cycles.
• •AI in medical imaging: Medical imaging accuracy and speed improved by seventy percent through AI applications in MRIs and CT scans. This advancement enables earlier detection of chronic diseases in aging populations, making preventive care more cost-effective. The shift from reactive to proactive healthcare delivery reduces overall system costs while improving patient outcomes.
• •Robotic surgery penetration: Three hundred million surgeries occur globally each year, with robotic surgery just beginning market penetration. Companies like Intuitive Surgical combine haptic feedback, mapping software, and advanced surgical technologies to reduce errors, simplify medical student training, and improve therapeutic outcomes while containing healthcare costs through better execution.
• •Private market disruption: Change happens at the edges, not the core, making private companies the most disruptive investment opportunities. Smaller private firms and emerging founders drive innovation at the margin across the four industry categories. Maintaining global networks to identify these edge opportunities provides insight into future market shifts before they reach public markets.